1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
申请人:Janssen R&D Ireland
公开号:US20150158862A1
公开(公告)日:2015-06-11
The present invention is concerned with novel 4-substituted 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles having formula (I)
tautomers and stereoisomeric forms thereof, and the pharmaceutically acceptable addition salts, and the solvates thereof,
wherein R
4
, R
5
, Z and Het have the meaning defined in the claims. The compounds according to the present invention are useful as inhibitors on the replication of the respiratory syncytial virus (RSV). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection.
本发明涉及具有式(I)异构体和立体异构体的杂环取代的新型4-取代-1,3-二氢-2H-苯并咪唑-2-酮衍生物,以及其药学上可接受的加合物盐和溶剂化物,其中R4、R5、Z和Het在权利要求中定义。本发明所述的化合物在呼吸道合胞病毒(RSV)的复制中具有抑制剂的作用。本发明还涉及制备这种新型化合物、包括这些化合物的组合物以及用于治疗呼吸道合胞病毒感染的化合物。